Pengfei Sui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pengfei Sui has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Xin Sun
Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Department of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA 92093, USA
3 shared publications - Feng Li
Department of Pulmonary and Critical Care Medicine, Shanghai Chest Hospital, School of Medicine Shanghai Jiao Tong University Shanghai People's Republic of China
2 shared publications - Gail H. Deutsch
Center for Respiratory Biology and Therapeutics Seattle Children's Research Institute Seattle Washington USA
2 shared publications Jiaying Yang
Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China
2 shared publicationsJiazhu Zhang
Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China
2 shared publications- Jinhao Xu
Department of Physiology, University of California, San Francisco, San Francisco, USA
2 shared publications
Latest Publications
- 23 October 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (11) , 2125-2142.e7
Mesothelial plasticity regulates lung mechanical homeostasis in regeneration and fibrosis
- 23 October 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (11) , 2125-2142.e7
Mesothelial plasticity regulates lung mechanical homeostasis in regeneration and fibrosis
- Open Access
- 7 October 2026
- Published by Springer Nature in Nature
- Vol. 659 (8139) , 186-196
Alveolar stem cells transdifferentiate to drive bronchiolar regeneration
- 7 October 2026
- Published by Springer Nature in Nature
- Vol. 659 (8139) , 186-196
Open AccessAlveolar stem cells transdifferentiate to drive bronchiolar regeneration
- Open Access
- 16 December 2024
- Published by Springer Nature in Cell Regeneration
- Vol. 13 (1) , 1-18
Unlocking lung regeneration: insights into progenitor cell dynamics and metabolic control
Regenerative responses are particularly important in the lungs, which are critical for gas exchange and frequently challenged by environmental insults. The lung progenitor cells play a central role in the lung regeneration response, and their dysfunction is associated with various lung diseases. Understanding the mechanisms regulating lung progenitor cell function is essential for developing new therapeutic approaches to promote lung regeneration. This review summarizes recent advancements in the field of lung regeneration, focusing on the metabolic control of lung progenitor cell function. We discuss cell lineage plasticity and cell–cell signaling under different physiological conditions. Additionally, we highlight the connection between progenitor cell dysfunction and lung diseases, emphasizing the need to develop new therapeutic strategies in regenerative medicine to improve lung regenerative capacity.
- 16 December 2024
- Published by Springer Nature in Cell Regeneration
- Vol. 13 (1) , 1-18
Open AccessUnlocking lung regeneration: insights into progenitor cell dynamics and metabolic control
Regenerative responses are particularly important in the lungs, which are critical for gas exchange and frequently challenged by environmental insults. The lung progenitor cells play a central role in the lung regeneration response, and their dysfunction is associated with various lung diseases. Understanding the mechanisms regulating lung progenitor cell function is essential for developing new therapeutic approaches to promote lung regeneration. This review summarizes recent advancements in the field of lung regeneration, focusing on the metabolic control of lung progenitor cell function. We discuss cell lineage plasticity and cell–cell signaling under different physiological conditions. Additionally, we highlight the connection between progenitor cell dysfunction and lung diseases, emphasizing the need to develop new therapeutic strategies in regenerative medicine to improve lung regenerative capacity.
- 18 October 2024
- Published by Elsevier in Cell Stem Cell
- Vol. 32 (1) , 105-120.e6
Mitochondrial pyruvate carriers control airway basal progenitor cell function through glycolytic-epigenetic reprogramming
- 18 October 2024
- Published by Elsevier in Cell Stem Cell
- Vol. 32 (1) , 105-120.e6
Mitochondrial pyruvate carriers control airway basal progenitor cell function through glycolytic-epigenetic reprogramming
- Open Access
- 1 October 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (19)
Viral infection induces inflammatory signals that coordinate YAP regulation of dysplastic cells in lung alveoli
Severe viral pneumonia can induce rapid expansion of KRT5 + basal-like cells in small airways and alveoli; this forms a scar-like structure that persists in the injured alveoli and impedes normal alveolar epithelium regeneration. In this study, we investigated the mechanism by which viral infection induced this remodeling response. Through comparing different lung-injury models, we demonstrated that infection induced strong IFN-γ signal–stimulated dysplastic KRT5 + cell formation. Inactivation of interferon receptor 1 ( Ifngr1 ) reduced dysplastic cell formation, ameliorated lung fibrosis, and improved lung-function recovery. Mechanistically, IFN-γ regulated dysplastic cell formation via the focal adhesion kinase (FAK)/Yes-associated protein 1 (YAP) pathway. Inhibiting FAK/Src diminished IFN-γ–induced YAP nuclear translocation and dysplastic cell formation. Inhibiting YAP during viral infection prevented dysplastic cell formation, whereas inhibiting YAP in persistent KRT5 + cells led to their conversion into distal club cells. Importantly, human dysplastic cells exhibited elevated FAK and YAP activity, and IFN-γ treatment promoted the transformation of human alveolar progenitor cells into dysplastic cells. These findings uncover the role of infection-induced inflammatory response in alveolar remodeling and may provide potential therapeutic avenues for the treatment of alveolar remodeling in patients with severe viral pneumonia.
- 1 October 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (19)
Open AccessViral infection induces inflammatory signals that coordinate YAP regulation of dysplastic cells in lung alveoli
Severe viral pneumonia can induce rapid expansion of KRT5 + basal-like cells in small airways and alveoli; this forms a scar-like structure that persists in the injured alveoli and impedes normal alveolar epithelium regeneration. In this study, we investigated the mechanism by which viral infection induced this remodeling response. Through comparing different lung-injury models, we demonstrated that infection induced strong IFN-γ signal–stimulated dysplastic KRT5 + cell formation. Inactivation of interferon receptor 1 ( Ifngr1 ) reduced dysplastic cell formation, ameliorated lung fibrosis, and improved lung-function recovery. Mechanistically, IFN-γ regulated dysplastic cell formation via the focal adhesion kinase (FAK)/Yes-associated protein 1 (YAP) pathway. Inhibiting FAK/Src diminished IFN-γ–induced YAP nuclear translocation and dysplastic cell formation. Inhibiting YAP during viral infection prevented dysplastic cell formation, whereas inhibiting YAP in persistent KRT5 + cells led to their conversion into distal club cells. Importantly, human dysplastic cells exhibited elevated FAK and YAP activity, and IFN-γ treatment promoted the transformation of human alveolar progenitor cells into dysplastic cells. These findings uncover the role of infection-induced inflammatory response in alveolar remodeling and may provide potential therapeutic avenues for the treatment of alveolar remodeling in patients with severe viral pneumonia.
- 17 March 2022
- Published by Elsevier in Developmental Cell
- Vol. 57 (7) , 839-853.e6
Excess neuropeptides in lung signal through endothelial cells to impair gas exchange
- 17 March 2022
- Published by Elsevier in Developmental Cell
- Vol. 57 (7) , 839-853.e6
Excess neuropeptides in lung signal through endothelial cells to impair gas exchange
- Open Access
- 2 February 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (6)
Loss of TET reprograms Wnt signaling through impaired demethylation to promote lung cancer development
Significance: Previous studies have identified the tumor-suppressive function of TET enzymes in hematological cancers. Given the differential mutational incidence and lacking functional validation, how TET contributes to carcinogenesis in solid tumors remains largely undefined. Here, we report that TET mutations co-occur with KRAS mutations, and such co-occurrence predicts poor survival in human LUAD. Using genetically engineered mouse models (GEMMs), we show that inactivation of TET cooperates with oncogenic KRAS to potentiate LUAD development, and that this effect is preferentially induced by augmented Wnt signaling as a consequence of impaired expression of Wnt-associated antagonists due to DNA hypermethylation. Our work reveals the tissue-specific and context-dependent roles of TET during carcinogenesis and implicates Wnt signaling as a therapeutic modality for TET -mutant lung tumors.
- 2 February 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (6)
Open AccessLoss of TET reprograms Wnt signaling through impaired demethylation to promote lung cancer development
Significance: Previous studies have identified the tumor-suppressive function of TET enzymes in hematological cancers. Given the differential mutational incidence and lacking functional validation, how TET contributes to carcinogenesis in solid tumors remains largely undefined. Here, we report that TET mutations co-occur with KRAS mutations, and such co-occurrence predicts poor survival in human LUAD. Using genetically engineered mouse models (GEMMs), we show that inactivation of TET cooperates with oncogenic KRAS to potentiate LUAD development, and that this effect is preferentially induced by augmented Wnt signaling as a consequence of impaired expression of Wnt-associated antagonists due to DNA hypermethylation. Our work reveals the tissue-specific and context-dependent roles of TET during carcinogenesis and implicates Wnt signaling as a therapeutic modality for TET -mutant lung tumors.
- 5 January 2022
- Published by Elsevier in Developmental Biology
- Vol. 483, 89-97
E3 ubiquitin ligase FBXW7 balances airway cell fates
- 5 January 2022
- Published by Elsevier in Developmental Biology
- Vol. 483, 89-97
E3 ubiquitin ligase FBXW7 balances airway cell fates
- Top Cited Papers
- 8 June 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 360 (6393) , 1086-+
Pulmonary neuroendocrine cells amplify allergic asthma responses
Finding a role for PNECs in asthma: Pulmonary neuroendocrine cells (PNECs) are a rare cell type located in airway and alveolar epithelia and are often in contact with sensory nerve fibers. They have a wide phylogenic distribution and are found even in the relatively primitive lungs of amphibia and reptiles, suggesting a critical function. Sui et al. found that mice lacking PNECs have suppressed type 2 (allergic) immune responses. PNECs were observed in close proximity to group 2 innate lymphoid cells (ILC2s) around airway branch points. The PNECs enhanced ILC2 activity by secreting CGRP (calcitonin gene-related peptide). They also induced goblet-cell hyperplasia via the neurotransmitter GABA (γ-aminobutyric acid). Interestingly, human asthma patients were found to have increased PNEC numbers, suggesting a potential therapeutic target for the treatment of asthma. Science , this issue p. eaan8546
- 8 June 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 360 (6393) , 1086-+
Top Cited PapersPulmonary neuroendocrine cells amplify allergic asthma responses
Finding a role for PNECs in asthma: Pulmonary neuroendocrine cells (PNECs) are a rare cell type located in airway and alveolar epithelia and are often in contact with sensory nerve fibers. They have a wide phylogenic distribution and are found even in the relatively primitive lungs of amphibia and reptiles, suggesting a critical function. Sui et al. found that mice lacking PNECs have suppressed type 2 (allergic) immune responses. PNECs were observed in close proximity to group 2 innate lymphoid cells (ILC2s) around airway branch points. The PNECs enhanced ILC2 activity by secreting CGRP (calcitonin gene-related peptide). They also induced goblet-cell hyperplasia via the neurotransmitter GABA (γ-aminobutyric acid). Interestingly, human asthma patients were found to have increased PNEC numbers, suggesting a potential therapeutic target for the treatment of asthma. Science , this issue p. eaan8546